Eris Lifesciences Ltd vs Sigachi Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of ERIS Lifesciences Ltd is ₹ 1322 as of 30 Apr 15:30 . The P/E Ratio of ERIS Lifesciences Ltd changed from 23.1 on March 2021 to 54.8 on March 2025 . This represents a CAGR of 18.86% over 5 yearsThe P/E Ratio of Sigachi Industries Ltd changed from 22.2 on March 2022 to 19.3 on March 2025 . This represents a CAGR of -3.44% over 4 years The Market Cap of ERIS Lifesciences Ltd changed from ₹ 8207 crore on March 2021 to ₹ 19287 crore on March 2025 . This represents a CAGR of 18.64% over 5 yearsThe Market Cap of Sigachi Industries Ltd changed from ₹ 888.92 crore on March 2022 to ₹ 1342 crore on March 2025 . This represents a CAGR of 10.85% over 4 years The revenue of ERIS Lifesciences Ltd for the Dec '25 is ₹ 807.59 crore as compare to the Sep '25 revenue of ₹ 795.5 crore. This represent the growth of 1.52% The revenue of Sigachi Industries Ltd for the Dec '25 is ₹ 117.68 crore as compare to the Sep '25 revenue of ₹ 117.63 crore. This represent the growth of 0.04% The ebitda of ERIS Lifesciences Ltd for the Dec '25 is ₹ 264.51 crore as compare to the Sep '25 ebitda of ₹ 291.3 crore. This represent the decline of -9.2% The ebitda of Sigachi Industries Ltd for the Dec '25 is ₹ 5.45 crore as compare to the Sep '25 ebitda of ₹ 14.67 crore. This represent the decline of -62.85% The net profit of ERIS Lifesciences Ltd changed from ₹ 89.55 crore to ₹ 108.83 crore over 7 quarters. This represents a CAGR of 11.79% The net profit of Sigachi Industries Ltd changed from ₹ 12.76 crore to ₹ -0.02 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of ERIS Lifesciences Ltd changed from 21.3 % on March 2021 to 129.35 % on March 2025 . This represents a CAGR of 43.44% over 5 yearsThe Dividend Payout of Sigachi Industries Ltd changed from 8.08 % on March 2022 to 8.02 % on March 2025 . This represents a CAGR of -0.19% over 4 years .

About ERIS Lifesciences Ltd

Eris Lifesciences Limited was incorporated on January 25, 2007.
Subsequently, the name of the company was changed to 'Eris Lifesciences Private Limited' on February 9, 2007.
Further, the Company was converted into a Public Limited cCompany and the name was changed to 'Eris Lifesciences Limited' on February 2, 2017.
The Company has a manufacturing plant in Guwahati, Assam and is presently engaged in manufacturing and marketing of pharmaceutical products.
It has presence in high growth chronic, sub chronic and acute therapeutic areas that require high intervention of specialist and super specialist doctors. The company develops, manufactures and commercializes branded pharmaceutical products in selected therapeutic areas within chronic and acute categories of the Indian Pharmaceutical Market (IPM), such as: cardiovascular; anti-diabetics; vitamins; gastroenterology; and anti-infective.

About Sigachi Industries Ltd

Sigachi Industries Limited was originally incorporated as 'Sigachi Chloro-Chemicals Private Limited' on 11 January, 1989.
To diversify the business activities, the name of Company was changed to 'Sigachi Industries Private Limited' on 29 March, 2012.
Subsequently, it was converted from a Private Limited to a Public Limited and the name was changed to 'Sigachi Industries Limited' on 19 December, 2019. The Company is is one of the major producer and distributor of Micro Crystalline Cellulose Powder(MCCP).
The Company currently offers 59 distinct grades of MCC through its two state-of-the-art manufacturing facilities in Hyderabad and Gujarat, with a total installed capacity of 11,880 MTPY. Apart from these, it is an industry leader in the field of Pharma Excipients, Nutra and food ingredients.

FAQs for the comparison of ERIS Lifesciences Ltd and Sigachi Industries Ltd

Which company has a larger market capitalization, ERIS Lifesciences Ltd or Sigachi Industries Ltd?

Market cap of ERIS Lifesciences Ltd is 18,325 Cr while Market cap of Sigachi Industries Ltd is 767 Cr

What are the key factors driving the stock performance of ERIS Lifesciences Ltd and Sigachi Industries Ltd?

The stock performance of ERIS Lifesciences Ltd and Sigachi Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for ERIS Lifesciences Ltd and Sigachi Industries Ltd?

As of May 4, 2026, the ERIS Lifesciences Ltd stock price is INR ₹1322.75. On the other hand, Sigachi Industries Ltd stock price is INR ₹20.08.

How do dividend payouts of ERIS Lifesciences Ltd and Sigachi Industries Ltd compare?

To compare the dividend payouts of ERIS Lifesciences Ltd and Sigachi Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.